Seamless Therapeutics, a German biotechnology firm, has successfully concluded a USD12.5 million Seed Financing, a university carve-out including equity financing, in-licensing of an innovative patent portfolio from Technische Universität Dresden and hiring of key personnel. Baker McKenzie provided legal and transactional IP advice to Seamless Therapeutics on the financing and in-licensing aspects of the transaction. […]
Tags : Baker McKenzie
Baker McKenzie has advised Transcom, a global customer experience specialist, on its acquisition of Forcontact, a customer services provider specializing in luxury fashion and retail e-commerce. With this purchase, Transcom aims to strengthen its attractiveness in the e-commerce luxury and retail CX market. At the same time, by joining the Transcom group, Forcontact benefits from […]
Baker McKenzie advised Zürcher Kantonalbank and Credit Suisse acting as joint arrangers, joint bookrunners and joint lead managers in connection with the issuance by First Swiss Mobility 2022-1 of CHF 218,800,000 2.43% asset-backed Class A Notes due 2031, CHF 22,400,000 4.00% asset-backed Class B Notes due 2031 and CHF 14,900,000 6.00% asset-backed Class C Notes […]
Baker McKenzie advised UBS on a transnational digital securities issuance using the distributed ledger technology (DLT). The USD 50 million fixed rate digital securities were placed in Singapore and Hong Kong and issued and settled on 15 December 2022. The transaction is an issue of uncertificated securities on chain which are constituted under English and […]
Baker McKenzie has advised Mövenpick Group in selling the multi-brand international catering company Marché International to Lagardère Travel Retail, the travel retail division of the French Lagardère Group. The sale completes the concentration process of the Mövenpick Group which intends to focus on its core competencies in fine foods and wine in Central Europe. The […]
Baker McKenzie has advised previous sole shareholder evotreex on selling its indirectly held equity interests in the German Zimmer & Hälbig to VR Equitypartner as well as on evotreex’s partial reinvestment into buyer. As a result of the transaction, VR Equitypartner has acquired a significant minority stake in Z&H, a provider of planning, installation and […]
Baker McKenzie, with lawyers from the Swedish and Swiss offices, acted as legal advisor to Skandinaviska Enskilda Banken (SEB) in their role as Issuer Agent of Swedish Depositary Receipts in connection with the spin-off of Accelleron Industries from ABB. Accelleron (formerly ABB Turbocharging), a global leader in high-power turbochargers for mission-critical applications, has been admitted […]
Baker McKenzie has advised Pilatus Aircraft on its acquisition of the American sales and services center Skytech. As part of an upcoming succession plan, Pilatus has decided to take over Skytech and the entire workforce of around 120 will continue to be employed by the Swiss aircraft manufacturer. This transaction will allow Pilatus to expand […]
Baker McKenzie has advised an investment fund managed by Highbridge Capital Management on a financing transaction for Invacare Corporation. Highbridge as lender and Invacare as borrower entered into an USD 104.5 million senior secured credit agreement providing for delayed drawdowns subject to certain conditions. Invacare completed an initial drawdown of USD 66.5 at the end […]
Baker McKenzie Switzerland, along with lawyers from the London and Amsterdam office, has advised Zur Rose Group on the placement of convertible bonds due 2026 and a capital increase through an accelerated bookbuilding (“ABB“) process. Zur Rose, via its subsidiary Zur Rose Finance B.V., completed the offering of unsecured bonds due in 2026 guaranteed and […]
